1. World Health Organization. Hepatitis C fact sheet. 2018.
https://www.who.int/news-room/fact-sheets/detail/hepatitis-c
. Accessed 19 Feb 2019.
2. European Association for the Study of the Liver. The burden of liver disease in Europe: a review of available epidemiological data. 2013.
http://www.easl.eu/medias/EASLimg/Discover/EU/54ae845caec619f_file.pdf
.
3. Schreiber J, McNally J, Chodavarapu K, Svarovskaia E, Moreno C. Treatment of a patient with genotype 7 hepatitis C virus infection with sofosbuvir and velpatasvir. Hepatology. 2016;64(3):983–5.
4. Esposito I, Trinks J, Soriano V. Hepatitis C virus resistance to the new direct-acting antivirals. Expert Opin Drug Metab Toxicol. 2016;12(10):1197–209.
5. European Medicines Agency. Summary of product characteristics: Victrelis. 2019.
https://www.ema.europa.eu/documents/product-information/victrelis-epar-product-information_en.pdf
. Accessed 2 Feb 2019.